| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |